US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jun 4, 2013 (13 years ago)

Cleocin Phosphate

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Presence of Particulate Matter: Firm is recalling a small number of vials with very small reflective flakes consistent with delamination of the glass vial.

What was recalled

Cleocin Phosphate (clindamycin Injection), USP, a) 600 mg/4mL (150 mg/mL) ADD-Vantage Vial, b) 900 mg/6mL (150 mg/mL) ADD-Vantage Vial, Rx Only, For Intravenous Use Only, Use Only with the ADD-Vantage diluent container, Distributed by Pharmacia & Upjohn Co, Division of Pfizer Inc, NY, NY 10017, NDC a) 0009-3124-03 and b) 0009-3447-03

Recalling firm
Pharmacia & Upjohn LLC
Origin
MI, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-609-2013

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Clindamycin recalls

See all
Class II · Moderate risk Ongoing

Clindamycin Palmitate Hydrochloride for Oral Solution

Reason Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles.

Heritage Pharmaceuticals Inc NDC 23155-603-51 D-0768-2026
Class III · Low risk Ongoing

Clindamycin Phosphate USP

Reason Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay.

Sun Pharmaceutical Industries INC NDC 51672-4081-4 D-0257-2026
Class II · Moderate risk Ongoing

Clindamycin HCl Capsule

Reason CGMP Deviations - products manufactured in a shared facility with Ezetimibe tablets.

RemedyRePack Inc. D-0411-2025
Class II · Moderate risk Ongoing

Clindamycin HCl

Reason CGMP Deviations

RemedyRepack Inc. D-0378-2025